Pharmaceuticals, Biotechnology and Life Sciences
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (“Revance”) (Nasdaq: RVNC), a biotechnology company developing next-generation neuromodulators for use in treating aesthetic…
NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for…
Early data trends from first patient dosed in the AVR-RD-04 investigational gene therapy program for cystinosis show improvements across multiple…
The U.S. Food and Drug Administration reviewed the Company’s request for Fast Track designation and concluded that investigation of NBTXR3…
SHANGHAI–(BUSINESS WIRE)–#Shanghai–Today is the first day of resuming work in Shanghai. The ATLATL Innovation Center held a solemn flag-raising ceremony…
CHICAGO–(BUSINESS WIRE)–Elorac, Inc., a biopharmaceutical company focused on developing best-in-class, innovative, proprietary drugs, announced that Scott Phillips, M.D., Sr. V.P.…
–Company is Recognized Top 1% among 4,000 applicants from 133 Countries– GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology…
LONDON–(BUSINESS WIRE)–#Healthcare–The healthcare IT market is poised to grow by USD 95.98 billion during 2020-2024, progressing at a CAGR of…